We are live on ! Find out more
GA

Greytown Advisors Portfolio holdings

AUM $170M
1-Year Est. Return 15.94%
This Fund
S&P 500
This Quarter Est. Return
-6.75%
1 Year Est. Return
+15.94%
3 Year Est. Return
+14.05%
5 Year Est. Return
+55.61%
10 Year Est. Return
AUM
$165M
AUM Growth
-$10.9M
Cap. Flow
+$2.36M
Cap. Flow %
1.43%
Top 10 Hldgs %
61.04%
Holding
104
New
3
Increased
30
Reduced
31
Closed
9

Sector Composition

Rank Sector Weight
1 Financials 6.97%
2 Healthcare 3.95%
3 Technology 2.38%
4 Consumer Discretionary 2.28%
5 Communication Services 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
26
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$997K 0.6%
12,570
+1,205
+11% +$102K
VNQ icon
27
Vanguard Real Estate ETF
VNQ
$39.6B
$970K 0.59%
12,104
+550
+5% +$51.4K
AMLP icon
28
Alerian MLP ETF
AMLP
$12.7B
$955K 0.58%
26,125
-9,507
-27% -$362K
BABA icon
29
Alibaba
BABA
$276B
$936K 0.57%
11,700
+374
+3% +$35.6K
C icon
30
Citigroup
C
$217B
$850K 0.51%
20,394
+357
+2% +$17.6K
CVS icon
31
CVS Health
CVS
$137B
$785K 0.47%
8,226
-705
-8% -$69.8K
MUE
32
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$770K 0.47%
78,938
META icon
33
Meta Platforms (Facebook)
META
$1.64T
$749K 0.45%
5,518
+125
+2% +$20.3K
VBF icon
34
Invesco Bond Fund
VBF
$170M
$745K 0.45%
51,713
JNJ icon
35
Johnson & Johnson
JNJ
$609B
$743K 0.45%
4,549
-1,113
-20% -$188K
USMV icon
36
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$739K 0.45%
11,186
-2,134
-16% -$154K
ABBV icon
37
AbbVie
ABBV
$450B
$725K 0.44%
5,404
-820
-13% -$118K
MQY icon
38
BlackRock MuniYield Quality Fund
MQY
$828M
$722K 0.44%
65,113
PFE icon
39
Pfizer
PFE
$143B
$721K 0.44%
16,481
-4,402
-21% -$214K
GS icon
40
Goldman Sachs
GS
$314B
$717K 0.43%
+2,448
New +$793K
PAYX icon
41
Paychex
PAYX
$40.7B
$681K 0.41%
6,073
BLW icon
42
BlackRock Limited Duration Income Trust
BLW
$496M
$673K 0.41%
55,629
BOND icon
43
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.29B
$670K 0.4%
7,469
REMX icon
44
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.18B
$635K 0.38%
7,620
BMY icon
45
Bristol-Myers Squibb
BMY
$124B
$611K 0.37%
8,597
-2,378
-22% -$173K
MCD icon
46
McDonald's
MCD
$190B
$567K 0.34%
2,458
-404
-14% -$103K
PEP icon
47
PepsiCo
PEP
$187B
$553K 0.33%
3,385
-546
-14% -$94.1K
CYBR
48
DELISTED
CyberArk
CYBR
$533K 0.32%
3,558
+4
+0.1% +$571
MPLX icon
49
MPLX
MPLX
$57.9B
$514K 0.31%
+17,115
New +$538K
PG icon
50
Procter & Gamble
PG
$349B
$503K 0.3%
3,985
-490
-11% -$69.6K

Similar funds

Greytown Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Greytown Advisors held 104 positions worth $165M, down 6.2% from $176M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Greytown Advisors's Q3 2022 filing shows 3 new, 30 increased, 31 reduced and 9 closed positions. Its largest new stake was Goldman Sachs: 2,448 shares worth $717K. The largest sale was Royalty Pharma, an estimated $3.55M.

By sector, the portfolio is most concentrated in Financials at 7% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Technology.

  • Greytown Advisors's largest Q3 2022 buy was Goldman Sachs: 2,448 shares worth $717K.
  • Greytown Advisors added most to Vanguard Mega Cap Growth ETF in Q3 2022, an estimated $1.65M increase.
  • Greytown Advisors's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $3.55M.
  • Greytown Advisors fully exited Vanguard Total International Stock ETF in Q3 2022, selling an estimated $465K.
  • Greytown Advisors's ten largest holdings make up 61% of its $165M portfolio in Q3 2022.
  • Greytown Advisors opened 3 new positions and closed 9 in Q3 2022.
  • Greytown Advisors's portfolio value fell 6.2% quarter-over-quarter to $165M.

Based on Greytown Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.